[SRY (sex determining region Y)-box 3] is considered to be one of the earliest neural markers in vertebrates, playing a role in specifying neuronal fate. We have previously reported characterization of the SOX3 promoter and demonstrated that the general transcription factors NF-Y (nuclear factor-Y), Sp1 (specificity protein 1) and USF (upstream stimulatory factor) are involved in transcriptional regulation of SOX3 promoter activity. In the present study we provide the first evidence that the TALE (three-amino-acid loop extension) transcription factors PBX1 (pre-B-cell leukaemia homeobox 1) and MEIS1 (myeloid ecotropic viral integration site 1 homologue) participate in regulating human SOX3 gene expression in NT2/D1 cells by direct interaction with the consensus PBX/MEIS-binding site, which is conserved in all mammalian orthologue promoters analysed. PBX1 is present in the protein complex formed at this site with nuclear proteins from uninduced cells, whereas both PBX1 and MEIS1 proteins were detected in the complex created with extract from RA (retinoic acid)-induced NT2/D1 cells. By functional analysis we also showed that mutations of the PBX1/MEIS1-binding sites resulted in profound reduction of SOX3 promoter responsiveness to RA. Finally, we demonstrated that overexpressed PBX1 and MEIS1 increased endogenous SOX3 protein expression in both uninduced and RAinduced NT2/D1 cells. With the results of the present study, for the first time, we have established a functional link between the TALE proteins, PBX1 and MEIS1, and expression of the human SOX3 gene. This link is of particular interest since both TALE family members and members of the SOX superfamily are recognized as important developmental regulators.
INTRODUCTION

SOX [SRY (sex determining region Y)-box] proteins belong
to the HMG (high-mobility group) box superfamily of DNA-binding proteins involved in the regulation of diverse developmental processes. They function in a complex interplay with other transcription factors in a manner highly dependent on cell type and promoter context [1] . Sox/SOX genes show diverse and dynamic patterns of expression and have been recognized as key players in the regulation of embryogenesis and nervous system development [2] . Improper functioning of SOX genes has been linked to a number of severe clinical disorders [2] [3] [4] .
Sox3/SOX3, an X-linked member of the family [5] , is involved in decisions about cell fate during development. It is implicated in the genetic cascades that direct gonadal development, brain formation and cognitive function [4, 6, 7] . Sox3/SOX3 is considered to be one of the earliest neural markers in vertebrates, playing a role in specifying neuronal fate [8] . Dysfunction of the SOX3 protein disturbs cellular processes required for cognitive and pituitary development, leading to mental retardation and growthhormone deficiency in humans [4] .
The homeodomain superfamily of DNA-binding proteins regulates transcription of many essential developmental genes during embryogenesis. The TALE (three-amino-acid loop extension) subclass of homeodomain proteins includes members of the MEIS (myeloid ecotropic viral integration site 1 homologue)/ PREP [PBX (pre-B-cell leukaemia transcription factor)-regulating protein] and PBX gene families [9] . PBX1, belonging to the PBX family, was initially identified as the chromosome 1 participant of the t(1;19) translocation, which creates a chimaeric gene designated E2A-PBX1 in a subset of pre-B-cell acute lymphocytic leukaemia in humans [10] . PBX genes play a central role in development and organogenesis and Pbx1-deficient mice exhibit an embryonic lethal phenotype characterized by defective organogenesis [11, 12] . Human MEIS1 has been cloned from BMH-2 myeloid tumours as a novel common oncogenic site of proviral integration [13] . Meis1-deficient mice also exhibit an embryonic lethal phenotype [14, 15] . In Xenopus laevis, Meis1b regulates hindbrain gene expression [16] , whereas ectopic expression of Meis caudalizes neural cell fates [17] .
PBX activity is regulated by other TALE proteins that form transcriptionally active complexes with PBX, which is important during embryonic development [18] [19] [20] . MEIS proteins have been shown to bind directly to PBX proteins [18, 20] . PBX1-MEIS1 heterodimers, whether formed in vitro or purified from nuclear extracts, displayed distinctive DNA-binding preferences for bipartite DNA sequences that adhere to a consensus, consisting of 5 PBX (TGAT) and 3 MEIS (TGACAG) half sites [20] . By interacting with both Hox and non-Hox factors, PBX-MEIS complexes contribute to both gene activation [21] and gene repression [22] . However, not all PBX targets require the DNAbinding activity of MEIS partners [23] .
NT2/D1 is the most widely characterized human EC (embryonal carcinoma) cell line [24, 25] . Upon RA (retinoic acid) induction, NT2/D1 cells differentiate into well-developed, morphological and immunophenotypic CNS (central nervous system) neurons [24] , providing an in vitro model for studying human genes that promote and regulate neural differentiation.
We have previously shown that early phases of differentiation and neural induction of NT2/D1 cells, which take place within 48 h of RA exposure, involve up-regulation of SOX3 gene expression [26] . In an attempt to delineate RA-responsive elements within the SOX3 promoter, we have previously described a few cis-regulatory elements [27] [28] [29] . Thus an atypical RXRα (retinoid X receptor α)-response element, located − 259 to − 154 relative to the TSP (transcription start point) [27] , as well as multiple CCAAT box control elements [28] , could be recognized as modulators of RA-induced activation of SOX3 gene expression. Recently, we have identified a novel positive regulatory promoter element involved in RA-dependent activation of SOX3 gene expression in NT2/D1 cells [29] . This element represents a direct repeat three-like motif that interacts with RXRα ( Figure 1a) . It is capable of independently mediating the RA effect in a heterologous promoter context, and its disruption causes significant reduction of RA/RXR transactivation of the SOX3 promoter.
In the present study we have identified a novel positive regulatory element within the SOX3 basal promoter region containing a PBX1/MEIS1-binding site which is conserved in mammals. Furthermore, we have demonstrated its functional relevance for both basal and RA-induced regulation of SOX3 gene expression in NT2/D1 cells.
MATERIALS AND METHODS
Cell culture, transfection and reporter gene analysis
NT2/D1 cells were maintained as reported previously [24] . Transfections with wild-type (F19R30) [30] or mutated SOX3 promoter-reporter constructs were performed as described previously [28] . Mouse Pbx1b and Meis1a cDNAs were released from pGEM3zf-Pbx1b and MSCV-Meis1a [a gift from Professor Mark P. Kamps (Department of Pathology, University of California San Diego, San Diego, CA, U.S.A.)] and cloned into the pCI mammalian expression vector (Promega) for co-transfection experiments, which were performed as described previously [27] . The pCH110 vector expressing β-gal (β-galactosidase) was used to adjust for differences in transfection efficiency. β-Gal and CAT (chloramphenicol acetyltransferase) activities were determined with a β-gal enzyme assay system (Promega) and a CAT ELISA (Roche) respectively. The normalized CAT activities were evaluated as a percentage of the promoter construct F19R30, which was set as 100 % activity and are presented as the means + − S.E.M. for at least four independent experiments. Mean values of relative CAT activities were compared using a Student's t test. Statistical analyses were performed using SPSS software. A P value of less than 0.05 was considered significant.
Sequence analysis of the SOX3 promoter region
Database searches and sequence alignment were performed using the NCBI (National Center for Biotechnology Information) and ClustalW software. The sequence of the human SOX3 promoter submitted under GenBank ® accession number AL121875.10 was aligned with orthologue promoter sequences of chimpanzee (GenBank ® accession number AC149044.1), rhesus macaque (GenBank ® accession number NW_001218193.1), rat (GenBank ® accession number NW_048052.2) and mouse (GenBank ® accession number NT_039706.6). The MatInspector Release professional program [31] was used to identify potential transcription factor-binding sites within the − 59 to − 96 protected promoter regions of SOX3 orthologues.
DNase I footprinting
The SureTrack Footprinting Kit (Amersham Pharmacia Biotech) was employed for DNase I footprinting. DNA was prepared by KpnI/XbaI (coding strand) and SacI/ClaI (non-coding strand) digestions of the clone F18R12 (− 293 to − 21, relative to the TSP) [27] which produced 272 bp and 273 bp DNA fragments respectively. DNase I footprinting reactions were performed under the conditions described previously [27, 28] .
Preparation of nuclear extracts
Nuclear extracts from NT2/D1 cells, uninduced or induced by 10 μM all-trans RA (Sigma) for 48 h, were prepared using standard procedures [32] .
PBX1 and MEIS1 were immunodepleted from nuclear extracts by incubation for 1 h at 4
• C with anti-PBX1 (C-20) and anti-MEIS1 (N-17) antibodies (Santa Cruz Biotechnology). This was followed by incubation for 30 min with Protein A/G-agarose (Santa Cruz Biotechnology) to recover immunocomplexes. After a brief centrifugation, the supernatant fraction was used in standard gel-shift assays. For mock depletion, nuclear extracts were incubated with Protein A/G-agarose, but no antibodies were added.
In vitro transcription/translation
Mouse Meis1a and Pbx1b cDNAs cloned in pGEM3zf-were a gift from Professor Mark P. Kamps and were used for in vitro syntheses of the proteins. The expression was carried out by transcription and translation in vitro using the TNT ® -coupled transcription/translation reticulocyte lysate (SP6 polymerase version; Promega) according to the manufacturer's protocol.
EMSA (electrophoretic mobility-shift assay) and supershift assay
The antisense strands of oligonucleotide probes used in EMSAs are shown in Figure 3 (a). Antisense oligonucleotides were designed to contain three unpaired G nucleotides at their 5 ends that were labelled with Klenow fragment and [α-
32 P]dCTP. The binding reactions were carried out as described previously [28] . Of the total product of each protein, 3 μl of the 50 μl was used in EMSAs with in-vitro-translated PBX1 and MEIS1 proteins, whereas 20 μg of protein was used in reactions with WCLs (whole-cell lysates). In competition analyses, a 100-fold molar excess of unlabelled competitor was included in the binding reaction. In the supershift assays, nuclear extracts were incubated with corresponding antibodies for 20 min at room temperature (24 • C) before the probe was added. The antibodies, anti-PBX1 (C-20), anti-MEIS1/2 (H-80) and anti-MEIS1 (N-17), were obtained from Santa Cruz Biotechnology.
Protein extraction after EMSA
After EMSA, protein was extracted as described previously [21] . Western blot analysis was performed with anti-PBX1 and anti-MEIS1 antibodies (Santa Cruz Biotechnology).
Site-directed mutagenesis
Mutant SOX3 promoter constructs (PBXMUT and MEISMUT) were generated by site-directed mutagenesis by PCR using the F19R30 promoter construct (− 427 to + 286 relative to the TSP) as a template, using the QuikChange ® Multi Site-Directed Mutagenesis Kit (Stratagene), according to the manufacturer's protocol, with the mutated primers shown in Figure 3 (a). Mutated constructs were sequenced to confirm that no other mutations occurred during PCR amplification. 
Western blot analysis
The WCLs were prepared from uninduced and NT2/D1 cells treated with 10 μM all-trans RA (Sigma) for 8, 16, 24, 32 and 48 h. Western blots were analysed as described previously [27] using an anti-α-tubulin (DM1A) antibody (Calbiochem) and anti-SOX3 (H-135), anti-PBX1 (C-20), anti-MEIS1 (N-17) and anti-actin (H-196) antibodies obtained from Santa Cruz Biotechnology.
Co-immunoprecipitation assay
The co-immunoprecipitation assay with the anti-MEIS1 antibody and WCLs from uninduced and RA-induced NT2/D1 cells was performed as described previously [33] . Western blots were analysed using an anti-PBX1 antibody (Santa Cruz Biotechnology).
RESULTS
DNase I protection analysis of the human SOX3 promoter region
In our initial characterization of the human SOX3 promoter we defined the minimal region (position − 219 to + 67, relative to the TSP) that confers basal promoter activity ( Figure 1a ) [30] . In order to define novel cis-acting control elements within the basal SOX3 promoter we used DNase I footprinting analysis. The region shown in Figures 1(b) and 1(c) was found to be protected in a reproducible manner on both the sense and antisense strands by proteins present in nuclear extracts from uninduced and RA-induced NT2/D1 cells. In silico analysis demonstrated that the protected region encompassed the putative PBX/MEIS heterodimer consensus site on the non-coding strand (position − 70 to − 79), consisting of 5 PBX (TGAT) and 3 MEIS (TGACAG) half sites ( Figure 1a) . Comparison of human, chimpanzee, rhesus macaque, rat and mouse sequences revealed that the putative PBX/MEIS heterodimer-binding site is conserved in both sequence and position in all SOX3 mammalian orthologues analysed (Figure 1a) . . In addition to specific recognition of homeoprotein complexes containing PBX and MEIS proteins in these cells, a non-specific stability effect was observed as shown by an increase in shifted band intensities upon antibody addition, as described previously [30, 34, 35] .
Specificity of PBX and MEIS binding to the SOX3 promoter
In order to investigate the specificity of PBX/MEIS binding to this site, gel-shift and supershift assays were carried out using labelled oligonucleotides with mutations within the PBX-or MEIS-binding half site (PBXMUT and MEISMUT) (Figure 3a) . Both mutated probes formed weak complexes compared with the wild-type probe (Figure 3b , compare lane 2 with lanes 9 and 16, and lane 3 with lanes 10 and 17), and no supershifted complexes were observed in the presence of anti-PBX1 and anti-MEIS1 antibodies (Figure 3b, lanes 11-14 and 18-21) . Interestingly, no supershifted complex formation was detected in reactions with anti-PBX antibodies when the MEIS half site was mutated (MEISMUT) (Figure 3b, lanes 18 and 19) . Moreover, mutation in the PBX half site abolished the formation of the supershifted complex with anti-MEIS1 antibodies (PBXMUT) (Figure 3b , lane 14). These results suggest that both intact half sites within the PBX/MEIS-binding site are necessary for efficient protein complex formation.
To confirm the absence of PBX1 and MEIS1 from complexes formed on mutated probes, we performed Western blot analysis on proteins from shifted EMSA complexes. Following gel-shift analysis and detection of complexes by autoradiography, regions of the gel corresponding to the shifted complexes were excised, run on SDS/PAGE and analysed by Western blotting using the anti-PBX1 and anti-MEIS1 antibodies (Figure 3c ). This analysis confirmed that PBX1 was present in the shifted complexes formed with nuclear proteins from both uninduced and RA-induced NT2/D1 cells in reactions with the wild-type probe (Figure 3c,  lanes 1 and 2) . On the other hand, MEIS was found only in a complex created with the same probe and nuclear proteins from RA-induced cells (Figure 3c, lane 2) . In complexes formed on mutated probes neither PBX1 nor MEIS1 were detected ( Figure  3c, lanes 3-6) , confirming the sequence-specific binding of these proteins to the analysed site within the SOX3 promoter. The sequence specificity of the complex formation was further examined in EMSA competition assays with the wild-type and mutant oligomers (Figure 3d ). As expected, the wild-type probe effectively competed against complex formation (Figure 3d, lanes  2 and 8) . PBXMUT was only able to compete partially (Figure 3d,  lanes 3 and 9) , whereas MEISMUT failed to compete against complex formation (Figure 3d, lanes 4 and 10) . No competition for complex formation was also observed with the probe with mutations in both half sites (PBX/MEISMUT, Figures 3a and 3d,  lanes 5 and 11) , as well as the non-homologous probe used as the control (Figure 3d, lanes 6 and 12) . These results (Figure 3d) confirmed that the sequence 5 -TGATTGACAG-3 is important for specific nuclear protein binding.
PBX1 and MEIS1 bind to the consensus site within the SOX3 promoter region
We further investigated the binding of in-vitro-translated PBX1 and MEIS1 proteins to the F31R31 probe. No binding activity was observed with in-vitro-synthesized PBX1 or MEIS1 proteins alone (Figure 4a, lanes 1 and 2) , whereas the presence of both proteins resulted in complex formation (Figure 4a, lane 3) . These results further demonstrated the ability of PBX1 and MEIS1 proteins to recognize and to bind the site within the F31R31 probe, which is in accordance with the finding that 5 -TGATTGA-CAG-3 is a high-affinity DNA-binding site for the heterodimeric PBX1/MEIS1 complex [20] . To further test the requirement for PBX1 and MEIS1 in complex formation, these proteins were immunodepleted by incubating nuclear extracts from uninduced and RA-induced NT2/D1 cells with specific antibodies. Depletion of PBX1 and MEIS1 from the extracts was monitored by EMSAs using the F31R31 probe (Figure 4c ). Immunodepletion of PBX1 or MEIS1 from the extracts markedly reduced nuclear protein binding compared with that of controls (Figure 4c , compare lanes 6 and 8 with lane 2, and lanes 7 and 9 with lane 3), indicating that these two factors are important contributors to this activity. There was no major change in complex formation in the mock-depleted extract (Figure 4c , compare lanes 4 and 5 with lanes 2 and 3).
PBX1 and MEIS1 up-regulate SOX3 expression in vivo in NT2/D1 cells
We have shown previously that early phases of differentiation and neural induction of NT2/D1 cells, which take place within 48 h of exposure to RA, involve up-regulation of SOX3 expression at both mRNA and protein levels [26] .
To examine the endogenous expression profiles of SOX3, PBX1 and MEIS1 proteins during early phases of RA induction, Western blot analysis were performed using WCLs from uninduced and NT2/D1 cells treated with RA for 8, 16, 24, 32 and 48 h (Figure 5a ). The expression of SOX3, PBX1 and MEIS1 proteins was detected in uninduced cells and exposure to RA revealed a transient decrease in the levels of all three proteins at the early hours of induction (8 h for SOX3 and MEIS1, and 16 h for PBX1). Subsequently, expression of all three proteins were up-regulated in parallel and remained significantly higher at time points 24, 32 and 48 h, compared with that of control. Thus the profiles of PBX1 and MEIS1 expression in response to RA are similar to that seen for SOX3, implicating them as potential mediators of RA-induced up-regulation of SOX3 gene expression in NT2/D1 cells.
Since it has been shown that MEIS proteins are major in vivo DNA-binding partners for wild-type PBX proteins [20] , we subsequently performed a co-immunoprecipitation assay to demonstrate the PBX1 and MEIS1 interaction in NT2/D1 cells (Figure 5b ). Endogenous MEIS1 was immunoprecipitated from nuclear extracts of NT2/D1 cells (uninduced and RA-induced) and the immune complexes were then subjected to Western blot analysis using an anti-PBX1 antibody (Figure 5b, lanes 1 and  2) . The detected protein co-migrated with the PBX1 protein in the positive control (WCLs from NT2/D1 cells) (Figure 5b , lane 5), thus confirming the interaction with MEIS1. Furthermore, we demonstrated that the amount of PBX1 protein associated with MEIS1 is increased upon RA treatment in NT2/D1 cells (Figure 5b, compare lanes 1 and 2) , which correlates with the results obtained in P19 cells [33] .
Our next step was to examine the effect of PBX1 and MEIS1 overexpression on the SOX3 protein level in a native context. Accordingly, we transfected NT2/D1 cells with PBX1 and MEIS1 expression constructs followed by Western blot analysis (Figure 5c ). The results clearly demonstrated the involvement of PBX1 and MEIS1 in the up-regulation of SOX3 expression in NT2/D1 cells (Figure 5c, lanes 3-8) . A particularly profound effect was observed when both proteins were overexpressed in the presence of RA (Figure 5c , lane 8 compared with lane 2). This in vivo analysis implies the involvement of PBX1 and MEIS1 proteins in the up-regulation of SOX3 expression in both uninduced and RA-induced NT2/D1 cells.
Functional analysis of the PBX/MEIS site within the human SOX3 promoter
To further explore the involvement of PBX1 and MEIS1 in regulating SOX3 promoter activity, co-transfection experiments were conducted in NT2/D1 cells. The F19R30 SOX3 promoterreporter construct was co-transfected with PBX1 and MEIS1 expression constructs. As shown in Figure 6 To determine whether the PBX/MEIS-binding site analysed in the present study is involved in the transcriptional regulation of SOX3 gene expression, we introduced mutations into this site within the F19R30 promoter construct and analysed their effects on SOX3 promoter activity in NT2/D1 cells (Figure 6b The wild-type and mutated constructs were additionally assayed for reporter activity in RA-induced NT2/D1 cells (Figure 6b ). Both PBXMUT and MEISMUT constructs exhibited considerable effects on RA responsiveness, reducing the promoter activity by approx. 70 % and 60 % respectively (compare lanes 4 and 6 with lane 2). While induction of the wild-type promoter construct F19R30 by RA was approx. 3.8-fold, significant decreases in induction were observed with mutated constructs (approx. 1.5-fold with PBXMUT and 2-fold with MEISMUT).
Taken together, the results indicate that the PBX/MEIS-binding site is of functional relevance for both basal and RA-mediated activation of SOX3 gene expression in NT2/D1 cells.
DISCUSSION
In the present study we have proceeded with further characterization of transcription factors that interact with the human SOX3 promoter and their potential roles in RA-mediated transcriptional activation of this gene. DNase I footprinting assays (Figure 1) revealed the presence of a protected region within the SOX3 basal promoter containing the sequence previously characterized as a high-affinity DNA-binding site for the PBX1/MEIS1 complex [18, 20] .
Our results demonstrated that PBX1 and MEIS1 proteins interact directly with this consensus binding site within the SOX3 promoter. PBX1 is present in the protein complex formed at this site with nuclear extracts from uninduced cells, whereas both PBX1 and MEIS1 proteins were detected in the complex created with extract from RA-induced NT2/D1 cells (Figure 2 ). Thus we have shown that PBX1, present in nuclear proteins from NT2/D1 cells, is capable of binding to this site in the absence of MEIS1. On the other hand, mutational analysis suggested that both half sites are necessary for efficient binding of PBX1 and MEIS1 proteins (Figure 3) , and that both mutations reduce SOX3 promoter activity ( Figure 6 ). Additionally, in-vitro-synthesized PBX1 and MEIS1 proteins are able to bind co-operatively to the site within the F31R31 probe, whereas neither protein can bind to this site alone (Figure 4a) . It has been shown that not all PBX targets require the DNA-binding activity of MEIS partners [23] . We can speculate that some other, not yet identified, protein(s) present in nuclear extracts from NT2/D1 cells can stabilize PBX1 binding in the absence of MEIS1, and that specific mutation within the MEIS1 half site interferes with the ability of this protein(s) to stabilize PBX binding.
Several results in the present study clearly demonstrated that PBX1 and MEIS1 proteins up-regulate SOX3 gene expression in uninduced NT2/D1 cells. First, overexpressed PBX1 and MEIS1 increased endogenous SOX3 protein expression in NT2/D1 cells ( Figure 5c ). Next, PBX1 and MEIS1 overexpression increased both reporter gene activity (Figure 6a ) and binding of cellular proteins to the SOX3 promoter (Figure 4b) . Finally, constructs with mutated PBX or MEIS half sites (PBXMUT and MEISMUT) reduced SOX3 promoter activity (Figure 6b ).
NT2/D1 cells induce a complex neuronal differentiation programme in response to RA [36] . The morphological changes, induction of early neuronal markers [36] and the ability of cells to differentiate into dopaminergic and GABAergic neurons [37] [38] [39] suggest that NT2/D1 cells provide an appropriate and convenient in vitro model to study early steps of neuronal differentiation and factors acting on this process during development and in the adult CNS [36] .
In the present study we show several lines of evidence demonstrating that PBX1 and MEIS1 positively regulate transcription of the SOX3 gene in NT2/D1 cells in response to RA. Although our analysis suggests that PBX1/MEIS1 regulate expression of SOX3 following RA treatment of NT2/D1 cells, we were unable to detect any difference in the timing of increased expression. However, SOX3, PBX1 and MEIS1 proteins exhibit synchronized profiles of up-regulation, showing significant increases after RA induction of NT2/D1 cells for 48 h (Figure 5a ). Furthermore, in vivo SOX3 protein expression was considerably increased when both PBX1 and MEIS1 were overexpressed in the presence of RA (Figure 5c ). Finally, functional and mutational analyses additionally confirmed PBX/MEIS involvement in SOX3 promoter responsiveness to RA (Figure 6 ). Thus we have identified a novel positive regulatory element comprising the consensus PBX/MEIS-binding site, accountable for RAdependent activation of SOX3 gene expression, at least in part.
PBX1 and MEIS1 proteins are up-regulated upon RA induction in various EC cells. Thus a time-dependent increase in Pbx1 protein level was demonstrated in RA-treated F9 mouse EC cells [40] . RA also enhanced the levels of PBX and MEIS proteins in mouse P19 EC cells [33, 41] . In line with these results, we have demonstrated that the PBX1 and MEIS1 protein expression is elevated in parallel with expression of SOX3, implicating them as effectors of RA, which induces neuronal differentiation of NTD2/D1 cells.
The PBX proteins are proposed to act as central developmental factors with a role in integrating transduction signals by interacting with numerous proteins, regulating gene expression programmes during development [42] . Numerous studies indicate that PBX proteins functionally interact with a wide variety of transcription factors, thus forming heterodimers, heterotrimers or multimers on the promoters of target genes that, like SOX3, play key roles in cell fate (reviewed in [42] ). Furthermore, it has been suggested that complexes containing PBX/MEIS-PREP1 function as accessory proteins that potentiate other more specific transcription factors [43] [44] [45] . As mentioned by several authors, heterotrimers or multimers made up of PBX/MEIS and PIPs (PBX-interacting proteins) are more efficient transcriptional regulators than PBX/MEIS heterodimers, suggesting that the latter need to co-operate with other transcription factors (reviewed in [42] ). In line with these results, our results demonstrated that, whereas PBX1 and MEIS1 overexpression enhances SOX3 expression in the native context ( Figure 5c ) and increases promoter activity in co-transfection assays (Figure 6a ), these proteins alone are not able to induce SOX3 activity in untreated NT2/D1 cells to the level seen in RA-induced cells. Accordingly, co-operation with other transcription factors on extended promoter sequences, not included in our reporter construct, is needed for efficient SOX3 transcriptional activation. In uninduced NT2/D1 cells, PIP(s) are probably either missing, or the amount is below the threshold necessary to achieve full activation of SOX3 gene expression.
It has been suggested that transcription of PBX target genes can be modulated by dynamic organization of transcription factors that physically interact with PBX1 in response to different cell signals [42] . The transcriptional effect of these interactions is likely to result in the integration of several signalling pathways, including those involving nuclear receptors. It has been proposed that the complex formed by interaction between TR (thyroid receptor)/RXR and PBX/MEIS1 may facilitate the recruitment of co-activators on to the malic enzyme promoter [46] . Additionally, the involvement of the homeobox protein PBX1 in glucocorticoid repression via a nGRE (negative glucocorticoidresponse element) highlighted an additional role for this protein in interfering with nuclear receptor signalling [47] . The results of the present study revealed that PBX1 and MEIS1 enhanced SOX3 gene responsiveness to RA by directly interacting with the consensus binding site immediately upstream to the RXRα regulatory element (Figure 1a) . Our results and previous results in the literature led us to hypothesize that full activation of the SOX3 promoter by RA might be mediated by co-operative interaction between the PBX1/MEIS1 heterodimeric complex and the complex consisting of the nuclear receptor RXRα bound to the nearby DR-3 (direct repeat 3)-like site. We speculate that accurate expression of the SOX3 gene during specific stages of development depends on differential usage and/or interplay of the multiple RA response elements within the promoter of this gene. Accordingly, our future work would be focused on defining the co-ordinated action of nuclear receptors and other transcription factors, particularly PBX1, MEIS1 and NF-Y (nuclear factor-Y), in the up-regulation of SOX3 gene expression during early stages of neural differentiation of NT2/D1 stem cells.
In the present study we have shown that PBX1 and MEIS1 are involved in transcriptional control of SOX3 expression during the commitment phase of NT2/D1 neuronal differentiation induced by RA. In order to evaluate the significance of these findings for in vivo regulation of SOX3 gene expression, we compared the existing expression profiles of these genes in the nervous system throughout development and in adulthood.
Several lines of evidence indicate that SOX3 plays an important role in mammalian neurogenesis. SOX3 is expressed throughout the neuroectoderm as it develops, mainly in proliferating neuronal precursors [6, 48] . It was demonstrated that SOX1-SOX3 maintain neural progenitor cells in an undifferentiated state by counteracting the activity of proneural proteins [49] . SOX3 continues to be expressed and to maintain neural progenitors in the adult brain [50] [51] [52] . Thus SOX3 is expressed transiently by neural stem cells and undifferentiated neural progenitors in the SVZ (subventricular zone), RMS (rostral migratory stream), the olfactory bulb subependymal, granular and glomerular layers and dentate gyrus [52] . These findings suggest that SOX3 continues to regulate mammalian forebrain neural stem/progenitor cell function throughout life. PBX1 is abundantly expressed in developing neuronal tissues, including some areas of the brain (most notably the cortex, as well as in the ventral telencephalon and SVZ), spinal cord and ganglia [53] [54] [55] . A region-specific pattern of Meis gene expression was demonstrated in mice, defining distinct subterritories in the developing telencephalon [55] . Similar to Sox3, a high level of Pbx1 expression was observed in the postnatal brain within the SVZ [53] . This was maintained along the rostral migratory stream to the olfactory bulb and in the granule and glomerular layers of the olfactory bulb that are targets of this migration [53] . Interestingly, the highest Meis1 expression was demonstrated in the SVZ and mantle regions of the ventral telencephalon, and its expression in the telencephalon remained unchanged at birth and even into adulthood [55] . Even though SOX3 is expressed more widely in the developing nervous system, preceding the expression of PBX1 and MEIS1 genes, all three genes are active in the developing brain, as well as in the SVZ that generates neurons in the postnatal period. Although all three genes are co-expressed in many regions in the embryo and some specific regions of the adult brain and in these sites, PBX1 and MEIS1 could be regulating SOX3 expression; in other regions, SOX3 expression must be regulated by other factors.
Although numerous data indicate that SOX3 is important for neural stem/progenitor cell function during development and throughout life, it is very likely that PBX1 and MEIS1, as its transcriptional regulators, also have regulatory roles in promoting neuronal differentiation and neurogenesis. For instance, SOX3 and PBX1 genes show overlapping expression profiles in the SVZ [52, 53] which serves as a source of neural stem cells that give rise to neuronal progenitors in the process of adult neurogenesis [56] . Additionally, it has been suggested that the PBX and MEIS proteins, probably through their interactions with Hox proteins, are key players in the control of neuronal differentiation of P19 cells [33, 41, 57] . Decreased PBX protein levels reduce neuronal differentiation in RA-treated P19 EC cells [57] . Taken together, the results of the present study and previously published results in the literature suggest important roles for SOX3, PBX1 and MEIS1 proteins in promoting neuronal differentiation and neurogenesis, by controlling proliferation, cell-fate determination and differentiation of neural progenitors.
In conclusion, in the present study we show that the transcription factors PBX1 and MEIS1 are involved in the regulation of human SOX3 gene expression in NT2/D1 cells by direct interaction with the newly identified consensus binding site within the basal promoter. Also, our results, for the first time, enabled us to establish a functional link between the TALE proteins, PBX1 and MEIS1, and expression of the human SOX3 gene. This link is of particular interest since both TALE family members and members of the SOX superfamily are recognized as important developmental regulators. Thus identification of PBX1 and MEIS1 as transcriptional regulators of SOX3 gene expression will ultimately provide some insight into the pathways that control neuronal differentiation and maturation during nervous system development and throughout life.
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